10
Participants
Start Date
December 15, 2025
Primary Completion Date
May 30, 2030
Study Completion Date
May 30, 2030
Ovarian tissue allo-transplantation
Participants will receive donor ovarian tissue with immunosuppression
University Hospitals Cleveland Medical Center, Cleveland
Rebecca Flyckt
OTHER